Barclays’s PHARMACYCLICS INC PCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-141,800
Closed -$36.2M 7463
2015
Q1
$36.2M Buy
141,800
+67,600
+91% +$13.1M 0.04% 423
2014
Q4
$9.05M Sell
74,200
-12,300
-14% -$1.57M 0.01% 1255
2014
Q3
$10.1M Buy
86,500
+35,300
+69% +$4.02M 0.01% 1165
2014
Q2
$4.56M Sell
51,200
-14,400
-22% -$1.35M ﹤0.01% 1830
2014
Q1
$6.56M Sell
65,600
-306,600
-82% -$39.9M 0.01% 1501
2013
Q4
$39.1M Buy
372,200
+212,900
+134% +$25.8M 0.04% 431
2013
Q3
$22M Sell
159,300
-137,900
-46% -$15.3M 0.03% 619
2013
Q2
$23.6M Buy
+297,200
New +$24.3M 0.03% 568

Other funds holding PCYC

Barclays's PCYC Position: Q2 2015 in Review

Barclays sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 189,579 shares — an estimated $48.3M sold.

Barclays first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $48.3M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • Barclays reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • Barclays sold 189,579 PHARMACYCLICS INC shares in Q2 2015, an estimated $48.3M.
  • Barclays first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • Barclays's PHARMACYCLICS INC position peaked at $48.3M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.